| Date | Title | Description |
| 22.12.2025 | Clinical ink announces collaboration with Tandem Diabetes Care to integrate Automated Insulin Delivery data into the GlucoseReady™ connected device software platform | Integration addresses critical need for accurate, real-time automated insulin delivery data in Type 1 Diabetes clinical research
WINSTON-SALEM, N.C., Dec. 22, 2025 /PRNewswire-PRWeb/ -- Clinical ink, a global life science technology company... |
| 21.11.2025 | 11 Recent Digital Health FDA Clearances You Need to Know: AI, Wearables, and Robotics Drive Precision Medicine Forward | What You Should Know:
– The U.S. Food and Drug Administration (FDA) has recently issued several key clearances, marking significant advancements across diagnostics, surgery, and remote patient monitoring.
– These FDA clearances reflect a de... |
| 30.10.2025 | Tandem Diabetes Care Launches t:slim X2 Pump Integration with Abbott FreeStyle Libre 3 Plus Sensor | What You Should Know:
– Tandem Diabetes Care, Inc. today announced that its t:slim X2 insulin pump, featuring the advanced Control-IQ+ automated insulin delivery (AID) technology, is now available with the integration of Abbott’s FreeStyle ... |
| 01.07.2025 | Stocks making the biggest moves midday: Tesla, Tandem Diabetes, GE Vernova, Hasbro and more | - |
| 20.06.2025 | Tandem’s t:slim X2 Insulin Pump Now Integrates with Abbott’s FreeStyle Libre 3 Plus Sensor | What You Should Know:
– Tandem Diabetes Care, an insulin delivery and diabetes technology company, today announced that its Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s ... |
| 19.03.2025 | Automated Insulin Delivery: Tandem Diabetes Unveils Control-IQ+ Enhancements | What You Should Know:
– Tandem Diabetes Care, a leader in insulin delivery and diabetes technology announced the U.S. commercial launch of Control-IQ+ technology.
– This update provides users with greater flexibility and control over their ... |
| 25.02.2025 | Tandem Diabetes Care Receives FDA Clearance for Control-IQ+ Technology for Type 2 Diabetes | What You Should Know:
– Tandem Diabetes Care, a insulin delivery and diabetes technology company, announced that its Control-IQ+ technology has received clearance from the U.S. Food and Drug Administration (FDA) for use by adults with type ... |
| 08.08.2024 | Fierce Competition and Technological Innovation Drive Diabetes Care Devices Market Towards Explosive Growth | OEMs Leading the Charge with AI-Equipped Technology and Novel Business Strategies
SAN ANTONIO, Aug. 8, 2024 /PRNewswire/ -- The diabetes care devices industry is witnessing a dynamic evolution, marked by intense competition among establishe... |
| 09.05.2024 | Баг в работе приложения t:connect для iOS затронул 224 пользователя инсулиновых помп t:slim X2 | Управление по санитарному надзору за качеством пищевых продуктов и медикаментов США (Food and Drug Administration, FDA) сообщило, что из-за бага в работе приложения t:connect mobile для iOS могли пострадать 224 пользователя инсулиновых помп... |
| 09.05.2024 | t:connect iOS App Recall: FDA Warns Users on Insulin Pump Problem | Joseph Henry, Tech Times 09 May 2024, 11:05 am
The FDA has issued an urgent Class I recall for version 2.7 of the t:connect iOS app, which interfaces with the t:slim X2 insulin pump, citing significant health risks including potential sever... |
| 09.05.2024 | Faulty insulin pump tech led to hundreds of injuries, prompting app ecall | Insulin prices capped for millions, but not all qualify
Insulin prices capped for millions, but not all qualify 02:20
More than 200 people with diabetes were injured after technology defect caused their insulin pump to unexpectedly shut dow... |
| 27.11.2023 | Unomedical A/S Recalls VariSoft Infusion Sets Due to Damage to the Connector Piece Causing Unexpected Disconnections | The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product
Product Names: VariSoft Infusion Sets
Product Codes: FPA
Model Numbers: 1002827, 10... |
| 16.12.2022 | AMF Medical SA sold in CHF 200 million exit deal | |
| 25.07.2022 | Tandem Diabetes Care Acquires Capillary Biomedical | Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a San Diego, CA-based global insulin delivery and diabetes technology company, acquired Capillary Biomedical, an Irvine, CA-based developer of technologies for diabetes and infusion set.
The amount ... |
| 24.11.2021 | A walk to remember: Teen's 100K trek for JDRF inspires a community | As the sun gave way to night and the clear skies yielded to rain, Ruby Pilatzke paused for a moment to do what she does best - she crunched the numbers.
Her goal was to walk 100 kilometers (62.1 miles) to celebrate the 100-year anniversary ... |
| 22.11.2021 | This Wearable Artificial Pancreas Device Helps Track Blood Glucose and Add Insulin—Here’s How | Teejay Boris, Tech Times 22 November 2021, 02:11 am
This wearable artificial device, which is smaller than the size of Apple's iPhone 13, could monitor and track the blood glucose of diabetic patients. On top of that, the tech could also in... |
| 18.11.2021 | Tandem Diabetes Care : Marcella Brooks helps UNLV women's soccer team stay goal-oriented | Marcella Brooks is all about chasing goals - the figurative and the literal ones.
As a center-forward for the UNLV women's soccer team, she spends her time on the field stalking the opponent's goal looking to score.
Off the field, however, ... |
| 10.11.2021 | ‘Work that matters' brought Tag Robison from the CIA to Tandem | It wasn't a quest for personal glory that compelled Tag Robison to join the Central Intelligence Agency a month after the attacks of Sept. 11, 2001.
It's not because Tag loves running into burning buildings that he became a volunteer firefi... |
| 28.10.2021 | Hashtag! You're it: Spreading the Tandem love on social media | TO ALL OF OUR FRIENDS IN THE SOCIAL-VERSE,
We use our social media platforms to connect with our friends and strengthen the Tandem Diabetes Care family bond, while also providing more information about Tandem.
We love to see you spreading t... |
| 27.09.2021 | Lifting the Nighttime Burden: The Power of Control-IQ Technology | As I look back on my early years with diabetes, starting with injections and fingersticks at 12 years old, I marvel at how I made it through. Managing diabetes at night is critical for physical and mental health. But it's also nerve-wrackin... |
| 22.09.2021 | Jerry's Journey: 100 Marathons (and Counting) with Type 1 Diabetes | It was back in 2009 when Jerry Nairn and I were at the starting line of the Carlsbad Marathon in Southern California. For Jerry, who has been living with type 1 diabetes since 1974, it was his 50th marathon/ultramarathon (anything beyond 26... |
| 09.09.2021 | Our Tandem Family Tree: Destiny Jackson | Whether you work at Tandem, or use our products, we consider you part of the Tandem Family. This series explores the roots of our Tandem Family Tree and introduces you to our family members outside of the company.
There's a phrase that Dest... |
| 09.09.2021 | Josh Juster: The man behind the Sugarmate app | Ironically enough, it was while Josh Juster was waiting at the eye doctor when he started to see things clearly.
Josh is/was/probably always will be obsessed with knowing his blood sugar number at all times, regardless of where he is. The '... |
| 03.09.2021 | Back in the saddle: Teen doesn't let T1D stop her from competing | There's a graceful irony to the sport Alivia Garwood has chosen to pursue.
The 13-year-old from just outside of Des Moines, Iowa, is an accomplished equestrian in the discipline of equitation - the art of horsemanship.
Garwood competes in S... |
| 10.08.2021 | Tandem Diabetes Care : How Control-IQ technology can help improve your sleep and time in range | The t:slim X2™ insulin pump from Tandem Diabetes Care has been a game-changer when it comes to increasing time in range (TIR)* and improving lack of sleep thanks to the Control-IQ® technology advanced hybrid closed-loop system.
Blood sugars... |
| 19.06.2021 | TANDEM DIABETES CARE, INC.
Tandem Diabetes Care : No joke, these two dads are amazing | Dad: He's often the keeper of jokes, master of grills, and navigator of hardware stores.
Dads can be lovable, tough, funny, and sensitive. They can be athletes, weekend warriors, and obsessive groundskeepers. Many of them love their tech, e... |
| 08.05.2021 | TANDEM DIABETES CARE, INC.
Ask your mother: Three moms share stories of their diabetes journey | Mary Ann Evans, the British poet and novelist who was better known by her pseudonym George Eliot, once penned: 'Life began with waking up and loving my mother's face.'
That was her 19th-century way of saying moms are awesome.
To celebrate M... |
| 28.04.2021 | Tandem Diabetes Care : People Behind the Pump - Get to Know the Field Sales Team | We sat down with several members of our field sales team to share their experiences working at Tandem Diabetes Care. In this Q&A, you'll hear from Annie Cooper (Territory Manager), Kevin Neff (Area Sales Director), and Trevor Thomson (T... |
| 16.04.2021 | TANDEM DIABETES CARE, INC.
Tandem Diabetes Care : People Behind the Pump – Jessica Kygar, Software Test Engineer Supervisor | Our products only tell half the story. At Tandem Diabetes Care, we put as much effort into standing behind our products as we do into designing and testing them. The passion within each person who works at Tandem is apparent. From product d... |
| 16.04.2021 | Tandem Diabetes Care : People Behind the Pump – Jessica Kygar, Software Test Engineer Supervisor | Our products only tell half the story. At Tandem Diabetes Care, we put as much effort into standing behind our products as we do into designing and testing them. The passion within each person who works at Tandem is apparent. From product d... |
| 14.04.2021 | Medical device company CeQur raises $115 million | |
| 14.04.2021 | Medical device company CeQur raises $115 million | The round is the largest fundraising to date for a privately held medtech company in Europe. Credit Suisse Entrepreneur Capital Ltd. and Endeavour Vision led the financing with significant participation from new investors, including Tandem ... |
| 17.12.2020 | Janie and Leonard: A Control-IQ Technology Love Story | Meet Janie and Leonard, an adorable Tennessee couple who enjoy low blood sugar picnics in the wee hours of the morning, positivity, and being beacons of encouragement to everyone they meet.
Janie, now 71, bubbles with Southern charm and con... |
| 16.10.2020 | TANDEM DIABETES CARE, INC.
Tandem Diabetes Care : Laila's Lunar Mission | Meet Laila England, a 13-year-old with an incredible dream. Like many kids her age, Laila aspires to become an astronaut when she grows up. Last summer while attending space camp in Huntsville, AL she learned some devastating news: people w... |
| 05.09.2018 | Should Medtronic’s return to the standalone continuous glucose monitoring market worry competitors? | Two weeks ago in a quarterly earnings call with analysts, Medtronic’s CEO, Omar Ishrak, painted a positive picture of the early adoption of the device. But the question is whether this will hurt competitors like Abbott and Dexcom who also m... |
| 13.08.2015 | Why Google and DexCom will change the Type 2 diabetes market | This trifecta could very soon herald very exciting products that would be ripe for a wide market – innocuous blood sugar monitoring system for those with mild diabetes, or an artificial pancreas that’s smart phone enabled for more serious c... |
| 06.03.2015 | Tandem Diabetes plans $60m offering | Medtech funding for the week of March 2, 2015 | Diabetes: Tandem plans $60m offering March 2, 2015 by Mark Hollmer
Tandem Diabetes Care said that it’s planning a $60 million public offering for its line of insulin pumps.
The San Diego, Calif.-based maker of the t:slim touch-screen insuli... |
| 07.01.2015 | HLM Venture Partners aiming at $150M for fourth investment fund | Perhaps its most noteworthy portfolio company is Teladoc, a telemedicine provider that last fall attracted a $50.2 million investment round.
Other portfolio companies are:
–Tandem Diabetes Care, a San Diego maker of a smartphone-like insuli... |
| 20.11.2013 | Tandem Diabetes closes $138M IPO | Tandem Diabetes Care (NSDQ:TNDM) closed its initial public offering yesterday after selling all 9.2 million shares on offer for $15 apiece, raising $138 million.
That’s a significant bump over the $120 million San Diego-based Tandem aimed t... |
| 15.11.2013 | Underwriters add $18M to Tandem Diabetes IPO | Tandem Diabetes Care (NSDQ:TNDM) said today that the underwrites of its initial public offering picked up a 1.2 million-share over-allotment at $15 per share, adding $18 million to the IPO’s value.
That means the San Diego-based medical dev... |
| 14.11.2013 | Tandem Diabetes Prices 8M Shares at $15 Apiece for IPO | San Diego-based Tandem Diabetes Care Inc. has upped the ante of its previously announced initial public offering, increasing the targeted goal from $100 million to $120 million.
The company will release 8 million shares priced $15 apiece. E... |
| 14.11.2013 | BREAKING: Tandem Diabetes shares surge 30% above IPO price | Shares of Tandem Diabetes Care (NSDQ:TNDM) are up some 30% today after the medical device company’s initial public offering debuted on the NASDAQ exchange.
TNDM shares opened and $19.40 apiece, 29.3% ahead of the $15-per-share price Tandem ... |
| 14.11.2013 | Tandem Diabetes prices $120M IPO | Tandem Diabetes Care is set to begin trading on the NASDAQ stock exchange today after pricing its initial public offering of 8 million shares at $15 each, the upper end of its initial range.
The amount the company actually raised could be h... |
| 14.11.2013 | UPDATE: Tandem Diabetes shares close 28% above IPO price | Shares of Tandem Diabetes Care (NSDQ:TNDM) closed up some more than 28% above their offering price today after the medical device company’s initial public offering debuted on the NASDAQ exchange.
TNDM shares opened at $19.40 apiece, 29.3% a... |
| 05.11.2013 | Tandem Diabetes details venture-backed $123M IPO | Tandem Diabetes Care upped the ante on its venture-backed initial public offering, increasing its maximum aggregate price to $123.2 million and pricing shares at between $13-$15 apiece.
The company, maker of the touch-screen t:slim insulin ... |
| 08.10.2013 | Tandem Diabetes Files for $100M IPO | San Diego-based Tandem Diabetes Care Inc. has filed for a $100 million initial public offering, making it the eighth area company to file for an IPO this year.
The other seven were biotechnology companies —Tandem is the first area medical d... |
| 14.03.2013 | Tandem Diabetes Care wins FDA clearance for new pump software | Tandem Diabetes Care won FDA clearance for its new web-based software, called t:connect, a PC- and Mac-compatible program designed for use with Tandem’s touch-screen t:slim insulin pump.
The t:connect system features HIPAA-compliant servers... |
| 10.10.2012 | iPhone glamour, functionality meets the diabetic insulin pump | The object of her devotion is the new t:slim insulin delivery system from San Diego-based Tandem Diabetes Care. As the first FDA-cleared touchscreen insulin pump, it is no ordinary medical device. Not only does it boast a touchscreen, the d... |
| 13.09.2012 | Maker of first touch-screen insulin pump raises $36M, starts shipping device | Money raised: $36.4 million of $50 million goal.
How it will be used: The money will be used to expand the company’s sales and marketing capacity. It will also be used to fund customer support systems and in research and development, said a... |
| 11.01.2010 |
Tandem Diabetes Nabs $31M
| San Diego-based Tandem Diabetes, a developer of insulin pumps, has raised another $31.0M in funding, bring its current funding round to $52.3M, according to a regulatory filing by the firm lsat week. Source of the new funding was not disclo... |
| 29.05.2009 |
Tandem Diabetes Gets $21.3M
| San Diego-based Tandem Diabetes, a developer of insulin pumps, has raised $21.3M out of a $52.3M funding round, according to a regulatory filing by the firm Friday. Details on the funding have not been released by the company. Tandem has pr... |
| 29.05.2009 | $21.4M for Tandem Diabetes | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Insulin pump developer Tandem Diabetes Care has raised $21.4 million in a $52.3 million financial round, according to a filing with the U.S. Securities and Exchange Commission... |
| - | HLM Venture Partners aiming at $150M for fourth investment fund | Medtech and health IT startups, listen up: Boston-based HLM Venture Partners is raising money for a fourth fund, with aims to bring in up to $150 million, a regulatory filing indicates.
The venture capital firm, which also has offices in Sa... |
| - | iPhone glamour, functionality meets the diabetic insulin pump | It’s probably not often that the delivery of a new insulin pump prompts a diabetic to upload a YouTube video of her breathlessly unwrapping the box.
Over the nearly 8 minute video, she repeatedly gushes over the device and its features.
“Oh... |
| - | Maker of first touch-screen insulin pump raises $36M, starts shipping device | Tandem Diabetes Care Inc. has developed the t:slim insulin pump delivery system combing the first touch-screen pump and a therapy management software called t:connect. The company began shipping the U.S. Food and Drug Administration-cleared... |
| - | Why Google and DexCom will change the Type 2 diabetes market | The new partnership between DexCom and Google to build out a new class of continuous glucose monitors spells out an interesting future for Type 2 diabetes care – and market dynamics in that space.
To that end there are three new DexCom deal... |
| - | Should Medtronic’s return to the standalone continuous glucose monitoring market worry competitors? | The Guardian Connect Continuous Glucose Monitoring System marks Medtronic’s return to the standalone CGM market it abandoned
Back in the day – roughly around 2007, Medtronic offered a standalone continuous glucose monitoring system where di... |
